A large body of preclinical and clinical data now documents that recombinant BMPs can be used for skeletal regeneration in humans and animals. Recombinant human BMP-2 and BMP-7 have been approved for use in human patients with long-bone fractures and nonunions and in patients undergoing lumbar fusion or various maxillofacial and dental regenerative procedures. These products have also been made available for veterinary use.
No takes yet. Share an insight, caveat, or question.
Kirker‐Head et al. (2007) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: